首页> 外文学位 >In vivo microdialysis to investigate serotonin and dopamine neurotransmission in mouse models of psychiatric and degenerative disease.
【24h】

In vivo microdialysis to investigate serotonin and dopamine neurotransmission in mouse models of psychiatric and degenerative disease.

机译:体内微透析研究精神病和退行性疾病小鼠模型中的血清素和多巴胺神经传递。

获取原文
获取原文并翻译 | 示例

摘要

The principle focus of this thesis was the investigation of alterations in neurochemistry using microdialysis in a number of strains of genetically engineered mice. The lines of mice selected for study model various aspects of human mood and anxiety disorders or Parkinson's disease (PD). Neurochemistry was investigated in serotonin transporter (SERT) knockout mice, brain-derived neurotrophic factor (BDNF) knockout mice and mutant human A53T α-synuclein (A53T-tg) transgenic mice to understand how each of these single gene alterations influence the function of the serotonin (5-HT) and dopamine (DA) neurotransmitter systems.; The first objective was to investigate alterations in basal and stimulated extracellular 5-HT or DA levels in specific brain regions, and to interpret these in light of the behavioral phenotypes of the mutant mouse models. In addition, SERT knockout mice were employed as tools to examine the neurochemical mechanisms of action underlying the locomotor-stimulating properties of the substituted amphetamines, 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH). The overarching objective of this thesis was to determine the ability of in vivo microdialysis to detect moderate, but biologically relevant changes in extracellular neurotransmitter levels occurring in response to alterations in the expression of proteins thought to directly or indirectly modulate neurotransmission.; In a second set of experiments, brain-derived neurotrophic factor knockout mice were studied to investigate an indirect modulatory role of BDNF in serotonergic neurotransmission. Mice with a 50% decrease in BDNF expression (BDNF+/−) show the following adaptations suggestive of changes in serotonergic signaling: a blunted c-fos response after d-fenfluramine (a selective 5-HT releasing amphetamine), accelerated age-dependent serotonergic neurodegeneration and brain region-specific changes in 5-HT receptor expression.; In addition, in vivo microdialysis was used to examine the effect of overexpression of mutant human A53T α-synuclein on DA neurotransmission.; In vivo microdialysis also was utilized to explore the relationship between MDMA- and METH-induced 5-HT and DA release in SERT knockout mice in an attempt to better understand the mechanisms by which these substituted amphetamines stimulate locomotor behavior. (Abstract shortened by UMI.)
机译:本论文的主要重点是利用微透析技术对许多基因工程小鼠品系中神经化学变化的研究。选择用于研究的小鼠品系可以模拟人类情绪和焦虑症或帕金森氏病(PD)的各个方面。在血清素转运蛋白(SERT)基因敲除小鼠,脑源性神经营养因子(BDNF)基因敲除小鼠和突变型人A53Tα-突触核蛋白(A53T-tg)转基因小鼠中对神经化学进行了研究,以了解这些单个基因改变如何影响它们的功能。血清素(5-HT)和多巴胺(DA)神经递质系统。第一个目标是研究特定大脑区域基础细胞和刺激细胞外5-HT或DA水平的变化,并根据突变小鼠模型的行为表型来解释这些变化。此外,SERT基因敲除小鼠被用作检查取代苯丙胺,3,4-亚甲二氧基甲基苯丙胺(MDMA)和甲基苯丙胺(METH)的运动刺激特性基础的神经化学作用机理的工具。本论文的总体目标是确定体内微透析检测被认为直接或间接调节的蛋白质表达变化所引起的细胞外神经递质水平中度但生物学相关变化的能力。神经传递。在第二组实验中,研究了脑源性神经营养因子敲除小鼠,以研究BDNF在血清素能神经传递中的间接调节作用。 BDNF表达下降50%(BDNF +/- )的小鼠表现出以下适应症,提示血清素能信号的变化:d-氟氟拉明后的 c-fos 反应变钝(选择性地释放5-HT的苯丙胺),加速了年龄依赖性的5-羟色胺能神经变性和5-HT受体表达的脑区域特异性变化。此外,采用体内微透析技术检测突变型人A53Tα-突触核蛋白过表达对DA神经传递的影响。为了研究MDMA和METH诱导的5-HT和DA在SERT基因敲除小鼠体内的释放之间的关系,还使用了体内微透析方法,以试图更好地了解这些取代的苯丙胺刺激运动行为的机制。 。 (摘要由UMI缩短。)

著录项

  • 作者

    Mathews, Tiffany Anne.;

  • 作者单位

    The Pennsylvania State University.;

  • 授予单位 The Pennsylvania State University.;
  • 学科 Chemistry Analytical.; Biology Neuroscience.; Health Sciences Pathology.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 245 p.
  • 总页数 245
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;神经科学;病理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号